WASHINGTON (Sept. 10, 2025) — The College of American Pathologists (CAP) President Donald S. Karcher, MD, FCAP, released the following statement regarding legislation introduced to reform the Protecting Access to Medicare Act (PAMA) and Medicare’s clinical laboratory fee schedule:
“The CAP supports congressional efforts to improve the PAMA rate-setting process for clinical lab services and reduce unnecessary burdens on laboratories. Under the current structure dictated by PAMA, the severity of fee reductions would undermine the operational infrastructure of clinical laboratories throughout the United States. The RESULTS Act will mitigate these cuts, avert needless loss in access to care, and allow laboratories to continue providing timely, high quality clinical services for patients. We urge Congress to pass the RESULTS Act before cuts take effect on January 1, 2026.
"We appreciate the leaders who are standing up for us and for our patients on this issue and look forward to working collaboratively to advance policies that strengthen the laboratory community.”
This legislation was introduced by Reps. Richard Hudson (R-NC), Gus Bilirakis (R-FL), Scott Peters (D-CA), Brian Fitzpatrick (R-PA), and Raja Krishnamoorthi (D-IL), and Sens. Thom Tillis (R-NC) and Reverend Raphael Warnock (D-GA).